Moreover, we demonstrated that P-cadherin inhibition decreases in vitro cell invasion and sensitizes breast cancer cells to radiation, as well as decreases in vivo tumorigenic ability, being indicated as a putative target for BLBC treatment [14]. Here, CDH3 is linked to breast carcinoma.